Posted inGenetics
AI-designed Antivenom Counteracts Toxins from Snakebites in Mice
Scientists led by 2024 Nobel Laureate in Chemistry David Baker, PhD, from the University of Washington (UW) School of Medicine,…
Posted inGenetics
Combining Protein Shapes with Genomic Sequences Improves Reliability of Evolutionary Trees
New research headed by scientists at the Centre for Genomic Regulation (CRG) has demonstrated how the three-dimensional shape of a…
Posted inGenetics
New Genetic Risk Factors for Depression Identified for First Time Across All Major Global Populations
Researchers say they have identified new genetic risk factors for depression across all major global populations for the first time,…
Posted inGenetics
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
SAN FRANCISCO—Kicking off J.P. Morgan week, Dyno Therapeutics announced that Roche has exercised its option to license a novel capsid…
Posted inGenetics
Maritime History Holds the Key to a Vaccine Manufacturing Powerhouse
The historical role of the British city of Liverpool as a trading port has helped it to become a center…
Posted inGenetics
Industry 4.0: A Digital Revolution Worth the Investment
Drug companies that do not use digital tech and automation in manufacturing are missing out, say researchers, who argue that,…
Posted inGenetics
Spirulina-Derived EVs Characterized for Adjuvant Applications
Spirulina has solid potential as a therapeutic adjuvant, according to researchers in Australia who isolated extracellular vesicles (EVs)—nanoscale vesicles enclosed…
Posted inGenetics
Building a Bioprocess for a Cancer-Fighting Biosimilar
In the next few years, atezolizumab will go off patent in the United States and Europe. This monoclonal antibody is…
Posted inGenetics
Illumina, Nvidia Launch AI-Based Genomics Partnership
SAN FRANCISCO—Nvidia will partner with Illumina to apply genomics and AI technologies to analyze and interpret multi-omic data in drug…
Posted inGenetics
Nanoscopy Unravels the Interplay Between Antibodies and CD20 in Immunotherapy
Therapeutic monoclonal antibodies (mAbs) are used in chronic lymphocytic leukemia immunotherapies to target the receptor CD20 at the plasma membrane…